First Oral Insulin For Diabetics Takes Major Step Towards FDA Approval
New York-based Oramed begins its largest clinical trial to date under FDA, recruiting type 2 diabetics across the country. New York, NY – May 16, 2018 – Oral insulin, the Holy Grail of diabetes care that has alluded researchers for decades, is taking a major step towards becoming reality. Oramed Pharmaceuticals Inc. (NASDAQ/TASE: ORMP), a clinical-stage […]
